Cannabis

Cannabis Corner, Key Insights by Adam Isaac Miller | Apr 13/2020

Reading Time: 2 minutes A note on psychedelics – Before they were banned about a half-century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders. Researchers say it’s time for regulators, scientists, and the public to ‘revisit drugs that were once used but fell out of […]

Cannabis Corner

Cannabis Corner, Key Insights by Adam Isaac Miller | Feb 16/2020

Reading Time: 2 minutes Europe offers growth opportunities for the next wave of cannabis organisations. The UK, Germany, Italy and the Netherlands already have legal systems in place for medicinal cannabis and France and Spain are currently reviewing key legislative reform to align themselves with international practices. In addition to medicinal cannabis, several key […]

Cannabis Corner

Cannabis Corner, Key Insights by Adam Isaac Miller | Feb 09/2020

Reading Time: 2 minutes Brazil and New Zealand share common fates as the two countries open up patients’ ability to access medical cannabis. Both countries emphasise GMP only products, meaning companies that intend to import into these countries require manufacture under EUGMP (or equivalent). This is however ambiguous, as the manufacturing process of cannabis […]

Cannabis Corner

Cannabis Corner, Key Insights by Adam Isaac Miller | Jan 12/2020

Reading Time: 2 minutes 3,682 medicinal cannabis prescriptions were approved via SAS Category B in December 2019. Prescriptions throughout 2019, increased month on month excluding November which dropped by 190 prescriptions compared to October. The only drop in prescriptions recorded before this was in December 2018 when prescriptions were lower than November numbers. As […]